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Abstract In Saccharomyces cerevisiae maltose utilization 
requires a functional MAL locus, each composed of three genes: 
MALR (gene 3) encoding a regulatory protein, MALT (gene 1) 
encoding maltose permease and MALS (gene 2) encoding 
maltase. We show that constitutive activation of the RAS/ 
protein kinase A pathway severely reduces growth of MALI 
strains on maltose. This may be a consequence of reduction in 
MALT mRNA, reduced Fm a x and increased catabolite inactiva-
tion of the M/lLJ-encoded maltose transporter in the MALI 
strain. Mutations in the GGS1ITPS1 gene, which restricts 
glucose influx and possibly affects signalling, relieve carbon 
catabolite repression on both maltase and maltose permease and 
reduce maltose permease inactivation. 
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1. Introduction 
The budding yeast Saccharomyces cerevisiae can utilize dif-
ferent sugars as a sole carbon source, depending on the pres-
ence of specific genes encoding enzymes required for sugar 
uptake and/or metabolism [1]. Glucose is the preferred carbon 
source and complex regulatory circuits have evolved to ensure 
that expression of gluconeogenetic and alternative sugar uti-
lizing enzymes is repressed when glucose is present in the 
growth medium. These mechanisms turn off gene expression 
at the transcriptional level - a mechanism known as glucose 
or catabolite repression [2] - and at the post-translational level 
by modulat ion of activity and/or enzyme degradation - a 
mechanism known as glucose or catabolite inactivation [3]. 
Although catabolite repression has been associated mostly 
with glucose, other sugars including sucrose and maltose are 
known to elicit it, but to a lesser extent. 
In addition to glucose derepression, full expression of cer-
tain genes, notably those required for galactose and maltose 
utilization [4,5] requires the presence of an inducer. Maltose 
utilization is dependent upon a multigene family. Each func-
tional MAL locus is composed of three genes: MALS (gene 2) 
encoding maltase, MALT {gens 1) encoding maltose permease 
and MALR (gene 3), encoding a transcriptional activator spe-
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cifically activating expression of the MALS and MALT genes. 
Expression of both MALS and MALT is carbon catabolite 
repressed by glucose and coordinately induced by maltose; in 
addition, maltose permease is catabolite inactivated by glu-
cose and - to a lesser extent - by maltose [5,6]. 
In S. cerevisiae RAS proteins exert their effects primarily -
if not exclusively - through the adenylyl cyclase/protein kinase 
A (PKA) pathway [7,8]. So far, few and conflicting reports 
have been published regarding interactions between genes of 
the RAS pathway and genes involved in - and subject to -
catabolite repression. Here we show that constitutive activa-
tion of the RAS/PKA pathway inhibits maltose utilization, 
mostly by reducing maltose permease activity. A mutat ion 
in the GGS1/TPS1 gene, encoding the catalytic trehalose-6-
phosphate synthase subunit of the trehalose synthase com-
plex, and which has been proposed to play a role in restricting 
glucose influx and possibly glucose sensing (reviewed in [9]) 
severely reduces glucose repression of MALS and MALT ex-
pression and strongly reduces catabolite inactivation of mal-
tose permease. 
2. Materials and methods 
2.1. Strains, media and growth conditions 
Escherichia coli strain JM101 was used as a recipient strain for 
plasmid transformation. E. coli cells were grown in LB medium sup-
plemented with 50 mg/1 ampicillin [10]. The S. cerevisiae MALI strain 
JM2763-14 (MATa ura3-52 leu2-3 leu2-112 MALI) has been described 
[11]. Strain MVY99 (MATa ura3 his3 lys2 fdpl) was constructed by 
crossing JM2763-14 with strain LVA1531 (MATa ura3 his3 lys2 fdpl) 
[12]. YEP and synthetic (S) [13] media - with appropriate amino acids 
and bases (50 mg/1) were supplemented with the appropriate carbon 
source as detailed below. Solid media contained 2% agar. [] indicates 
plasmid-carrying cells. 
2.2. Enzyme assays 
Specific activities of maltase, ß-galactosidase and [14C]maltose up-
take were determined essentially as described previously [14-16] ex-
cept that 5 s of incubation were used for measuring [14C]maltose 
uptake. Kinetic parameters of maltose permease were determined 
with 5 different maltose concentrations: 20, 10, 4, 2, and 1 mM. 
Protein content was measured by Bio-Rad protein assay reagent (Bio-
rad). Inactivation of maltose permease was determined by measuring 
[14C]maltose uptake of cells grown on synthetic medium - containing 
0.1% glucose+2% maltose - washed with sterile double-distilled water 
and placed into synthetic medium containing 5% glucose at time zero. 
Maltose permease activity of the culture was followed for at least 60 
min. 
2.3. Recombinant DNA techniques and plasmids 
Standard procedures for DNA subcloning and plasmid construction 
were as described in [10]. Yeast transformation was performed using 
the lithium acetate method described by Ito et al. [17] or the DMSÓ 
lithium acetate method of Hill et al. [18]. Plasmids pRAS2, 
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pRAS2valls> [19] and pTPKl [20] were used to obtain strains JM2763-
14 [pRAS2], JM2763-14 [pRAS2™119] and JM2763-14 [pTPKl], Plas-
mids pFDPl (carrying GGS1ITPS1) and pFPSl (carrying FPS1) [12] 
were used to obtain strains MVY99 [pFDPl] and MVY99 [pFPSl]. 
Strain JM2763-14 bcyl::URA3 was obtained by the one-step gene 
disruption method [21] using BamHI-cut plasmid pbcyl: :URA3 [22] 
selecting for Ura+ transformants. Disruption of the BCYl gene was 
confirmed by Southern blotting [10]. MALS- and MALT-lacZ fusions 
were constructed by subcloning the same £"coRI(blunted)-ßcfl frag-
ment encompassing nucleotides 1-17 of MAL6S, nucleotides 1-92 of 
MAL6T and the complete region between the divergently transcribed 
genes into appropriate lacZ fusion vectors [23]. Cloning of the 
£"coRI(blunted)-ßcfl into Smal-BamHl-cut YEp368 and of the BcK-
£coRI(blunted) into BamK\-Sma\-cxxi YEp366R yielded plasmids 
pMSlac and pMT/ac, expressing MAL6S- and M^LöT-fusions, re-
spectively. 
2.4. Hybridization techniques 
Total yeast RNA for Northern blot analysis was isolated, electro-
phoresed, blotted and hybridised with random primed probes essen-
tially as described previously [24]. Probes for MALR, MALS and 
MALT were the £coRI-£coRI fragment of MAL6R, the Bglll-Bglll 
fragment of MAL6S and the Ncol-Pvull fragment of MAL6T, respec-
tively. 
3. Results 
3.1. Maltose utilization is inhibited in strains with an activated 
RASIprotein kinase A pathway 
Constitutive activation of the RAS/PKA pathway inhibits 
growth on maltose of the JM2763-14 strain regardless of 
whether activation is brought about by deregulated RAS ac-
tivity - strain JM2763-14 [pRAS2va119] - or by deregulated 
protein kinase activity - strains JM2763-14 bcyl:: URA3 lack-
ing PKA regulatory subunit - or JM2763-14 [pTPKl], over-
expressing PKA catalytic subunit. The same results were ob-
tained at either 24, 30 or 37°C in both liquid and solid media 
and indicate that expression of one or more of the MAL genes 
is directly or indirectly reduced by unbridled PKA activity. 
Growth on maltose of the JM2763-14 strain with an activated 
RAS pathway (strain JM2763-14 [pRAS2™119]), but interest-
ingly not of JM2763-14 bcyl:: URA3 was at least partially 
restored by growing cells in 10% maltose, a feature often 
associated with mutants in maltose permease, thus suggesting 
that maltose transport is the major target affected by an over-
active RAS pathway (data not shown). 
3.2. Constitutive activation of the RAS/PKA pathway 
preferentially affects maltose permease at both 
transcriptional and post-transcriptional levels 
JM2763-14-derived strains were then analyzed for their 
ability to synthesize maltase and maltose permease under 
standard inducing conditions (overnight growth in synthetic 
medium supplemented with 0.1% glucose+2%> maltose). Table 
1 shows that JM2763-14 [pRAS2va119] and JM2763-14 
bcyl:: URA3 strains synthesize maltase levels close to the 
wild type strain or to strains expressing a second RAS2 
gene. In contrast, the level of maltose permease was severely 
reduced in both strains. By growing JM2763-14 [pRAS2™119] 
cells in 10% maltose nearly normal levels of maltose permease 
activity were regained. Strain JM2763-14 bcyl::URA3 grew 
poorly, if at all. 
The expression of each MAL gene was examined by North-
ern blotting using subcloned MAL gene fragments as probes. 
Levels of MALR and MALS mRNAs were close to wild type 
as expected. The decrease in MALT mRNA was more severe 
for the JM2763-14 bcyl::URA3 strain than for the JM2763-
14 [pRAS2va119] strain (Fig. 1), in keeping with the more se-
vere phenotype of the former. 
Both MALS- and MALT-lacZ fusions were constructed 
and their expression examined under steady-state inducing 
conditions. Table 1 shows that in both JM2763-14 
[pRAS2va119] and JM2763-14 bcyl::URA3 mutant strains, ß-
galactosidase levels driven by MALS promoter are close to 
the levels found in the wild type. Expression of MALT-lacZ 
fusions is reduced in both strains, but to a significantly higher 
degree in JM2763-14 bcyl:: URA3. These results indicate that 
post-transcriptional regulation of maltose permease is a key 
factor in the Mal - phenotype of MALI strains of which the 
RAS pathway is constitutively activated. The more severe 
reduction of MALT-lacZ expression in strain JM2763-14 
bcyl:: URA3 is in keeping with results obtained with maltose 
permease assays and MALT Northern blots. 
Kinetic parameters of maltose permease were examined in 
JM2763-14 [pRAS2va119] and compared with those of its iso-
genic counterpart JM2763-14 [pRAS2]. The apparent Km val-
ues determined for JM2763-14 [pRAS2] and JM2763-14 
[pRAS2va119] agreed within the experimental error (15%), 
while the apparent Vmax dropped to less than 50% in 
Table 1 
Effect of unbalanced RAS/cyclase pathway on maltase, maltose permease and the expression of MALS and MALT -lacZ fusions 
Strain 
Genotype 
MALI BCYl 
MALI BCYl 
MALI BCYl 
MALI bcyl:: URA3 
Plasmid 
pRAS2 
pRAS2va119 
0.1% D 2% M 
Maltase 
1.03 
1.00 
0.70 
0.81 
MALS-lacZ 
0.9 
1.0 
0.8 
0.2 
Maltose 
permease 
0.84 
1.0 
0.15 
0.15 
MALT-lacZ 
1.05 
1.0 
0.64 
0.07 
10% M 
Maltase 
0.97 
1.00 
1.00 
NG 
MALS-lacZ 
1.08 
1.00 
1.04 
NG 
Maltose 
permease 
0.94 
1.00 
0.82 
NG 
MALT-lacZ 
1.1 
1.00 
0.41 
NG 
NG, no growth. Maltase and maltose permease specific activities of JM2763-14 derivatives grown on 0.1% glucose+2% maltose and on 10% 
maltose were determined as described in Section 2.2. The values (average of at least two independent experiments, each conducted in duplicate and 
triplicate for maltase and maltose permease, respectively) are expressed as a fraction of either maltase specific activity (28-32 OD^/min per mg 
protein) or [14C]maltose uptake (300^400 cpm/min per ug protein) of the JM2763-14 [pRAS2] strain grown under the same conditions. Results of 
different experiments agreed within 10 and 20% for maltase and maltose permease, respectively. ß-Galactosidase specific activities of mutant strains 
transformed with MALS- and MALT-lacZ fusions were determined as previously described [16]. The values (average of at least three independent 
experiments, each assayed in duplicate) are expressed as a fraction of ß-galactosidase activity (45-50 and 29-33 OD42o/min per mg of protein for 
MALS and MALT fusions, respectively) of the JM2763-14 [pRAS2] strain grown under the same conditions. Results of different experiments 
agreed within 20%. 
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Fig. 1. Top panels show Northern blot analysis of MAL gene expression in JM2763-14 strains transformed with the pRAS2 plasmid (lanes 1,2) 
or with the pRAS2va119 plasmid (lanes 3,4) and in JM2763-14 bcyl::URA3 strain (lane 5). Total RNA was prepared after growth on 0.1% glu-
cose+2% maltose and on 10% maltose. The blots were probed with random primed MALR, MALS and MALT probes. Bottom panels show 
rRNA corresponding to each lane. 10 ug of total RNA were loaded on each lane for MALS and MALT, 50 ug for MALR analysis. 
JM2763-14 [pRAS2va119] compared to its isogenic counterpart. 
Accumulation of maltose permease may depend not only on 
its synthesis, but also on its degradation. Unlike maltase, in 
fact, maltose permease is known to be subject to carbon ca-
tabolite inactivation [3,5,25,26]. We thus investigated whether 
maltose permease inactivation was faster in JM2763-14 
[pRAS2va119] than in JM2763-14 [pRAS2]. The decrease in 
specific activity of maltose permease upon glucose addition 
is the result of both dilution - due to protein synthesis -
and inactivation. Dilution is very different for wild type cells 
and JM2763-14 [pRAS2™119] since whilst the wild type starts 
accumulating proteins almost immediately, JM2763-14 
[pRAS2va119] cells increase their cell mass only after approx. 
30 min. Because of the initial absence of the dilution term, 
plotting of inactivation data in the usual manner, i.e. as % of 
initial specific activity, artefactually indicates that inactivation 
in JM2763-14 [pRAS2va119] is slower than in wild type (Fig. 
2A). When data are replotted as a difference between the 
actual data and those expected for dilution only, it can be 
appreciated that cells expressing the RAS2valw alíele inactivate 
maltose permease faster than cells expressing the wild type 
alíele (Fig. 2A, insert). As a whole, the above-mentioned re-
sults indicate that deregulation of the RAS/PKA pathway 
affects maltose permease at both the transcriptional and 
post-transcriptional levels. 
3.3. Mutations in the FDP1IGGS1ITPS1 gene relieve carbon 
catabolite repression and inactivation of maltase and 
maltose permease 
Mutants in the GGS1ITPS1 gene have been shown to dis-
play reduced glucose signalling [12]. We thus tested whether 
ggsl/tspl mutations reduce catabolite repression of MALS 
and MALT expression in a defined MALI background. Cells 
of strain MVY99 (fdpl, an alíele of ggsl/tpsl) transformed 
with centromeric plasmids carrying either the wild type 
GGS1ITPS1 gene (pFDPl) or a suppressor gene allowing 
growth on glucose while not relieving the regulatory defects 
(pFPSl) were grown to mid-exponential phase in synthetic 
media supplemented with either 2% glucose, 2% maltose or 
2% maltose+2% glucose. Table 2 shows that the ggsl/tpsl 
mutation strongly decreases glucose repression of both mal-
tase and maltose permease, but only when maltose is present 
in the medium. Results obtained by analyzing the expression 
of each MAL gene by Northern blotting are shown in Fig. 3 
and are consistent with the enzymatic data. Analysis of glu-
cose inactivation of maltose permease indicated that the ggsll 
tpsl mutation strongly stabilizes maltose permease. It was 
completely stable for at least 15 min, and retained as much 
as 30-50% of activity after 60 min in the presence of glucose 
while in the isogenic wild type strain only 0-5% of the initial 
activity remained (Fig. 2B). 
Table 2 
Effect of mutations in the GGS1ITPS1 gene on catabolite repression of maltase and maltose 
Plasmid 
pFDPl 
pFPSl 
2% glucose 2% glucose+2% maltose 
Maltase Maltose permease Maltase Maltose permease 
0.05 0.05 0.03 0.03 
0.03 0.05 0.4 0.2 
permease 
2% maltose 
Maltase Maltose permease 
1.0 1.0 
1.0 1.0 
Maltase and maltose permease specific activities of MVY99 (relevant genotype MALI ggslltpsl) transformants grown on indicated carbon sources 
were determined as described in Section 2.2. The values (average of at least two independent experiments, each conducted in duplicate and triplicate 
for maltase and maltose permease, respectively) are expressed as a fraction of either maltase specific activity (50-80 OD^/min per mg protein) or 
[14C]maltose uptake (800-1100 cpm/min per ug protein) of each strain grown in 2% maltose. Results of different experiments agreed within 10 and 
20% for maltase and maltose permease, respectively. 
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time (min) 
Fig. 2. Catabolite inactivation of maltose permease as a function of 
the time after addition of glucose (see Section 2) in JM2763-14 
[pRAS2] (■), JM2763-14 [pRAS2™119] (□) (A) and in MVY99 
(MALI ggslltpsl) untransformed (•), transformed with pFDPl (■) 
or with pFPSl ( A ) plasmids (B). In the insets in A and B the frac-
tional difference between the theoretical specific activity of maltose 
permease - expected according to dilution - and the actual meas-
ured specific activity is plotted as a function of time after glucose 
addition (time = 0). 
4. Discussion 
Since several laboratory strains have a poorly characterized 
MAL genotype and are often Mal", only few data are avail-
able on the role of the RAS/PKA pathway in maltose utiliza-
tion. In particular, the inability of a bcyl strain to grow on 
maltose plates at 37°C has been reported, but the molecular 
basis of this defect was not further investigated [27]. We ad-
dressed this aspect by assaying enzyme activity and mRNA 
levels of MAL genes, MALS- and MALT-lacZ gene fusions 
and catabolite inactivation of maltose permease. Expression 
of maltase-encoding MALS is essentially unaffected by de-
regulated PKA activity, in keeping with the results of a pre-
vious study that failed to detect any effect of the RAS/PKA 
pathway on maltase expression [28]. MALT expression ap-
pears to be more affected than MALS; these results fit with 
the previously reported preferential sensitivity of MALT ex-
pression - compared to MALS - to alterations in the bidirec-
tional UASMAL promoter [29]. In contrast, deregulated PKA 
severely reduces the Fmax of maltose permease (as well as 
expression of MALT mRNA and MALT-lacZ fusions) under 
steady-state growth on maltose and decreases its half-life 
upon glucose addition. Although conflicting results on the 
role of the RAS/PKA pathway on steady-state levels and ca-
tabolite inactivation of sugar transporters have been reported 
[30,31], our data - being complemented by previously unavail-
able data on mRNA levels or promoter activity - strongly 
point towards a role for cAMP in regulation of maltose per-
mease levels. Since maltose itself is a catabolite repressing 
sugar, maltose permease inactivation may be the primary mal-
tose-related phenomenon brought about by deregulated acti-
vation of the RAS/PKA pathway. Because of the reduced 
levels of maltose permease activity, a secondary reduction in 
the intracellular maltose pool may arise, resulting in decreased 
transcription of the MAL genes. 
A role for cAMP in catabolite inactivation of proteins was 
previously shown for soluble proteins (see for instance [32]). 
Our data regarding inactivation of the maltose transporter in 
the RAS2mm mutant indicate a role for the RAS/PKA path-
way in maltose permease activity and turnover, and suggest 
that PKA-dependent phosphorylation could be the first event 
leading to the reduced activity of maltose permease mediated 
by glucose and possibly other fermentable sugars. A potential 
phosphorylation site for PKA is present on maltose permease 
[5]. Moreover, a recent study reports that maltose permease is 
present in differentially phosphorylated forms in maltose-
grown cells and that the hyperphosphorylated species accu-
mulate in glucose-grown cells [26]. Whether maltose permease 
itself or an element(s) of the proteolysis machinery is the 
target of PKA remains to be seen. In at least one well-studied 
case, in fact, PKA-dependent phosphorylation of FBPase was 
shown to be dispensable for its eventual proteolysis [33-35]. 
Recently, it has been reported that glucose affects the ex-
pression of MALT and MALS genes through two independ-
ent mechanisms: a MIG1-dependent mechanism is operative 
in the presence and absence of maltose, whereas another 
MIG1-independent mechanism is operative only in the pres-
ence of maltose and may involve inhibition of the induction 
process [36]. Our results suggest that GGS1/TPS1 may act 
through this second mechanism. 
In conclusion, in keeping with data obtained for SUC2 and 
ADH2 expression [37,38], our data indicate that the RAS/ 
Fig. 3. Top panels show Northern blot analysis of MAL gene expression in MVY99 (MALI ggslltpsl) transformed with the GGS7-bearing 
pFDPl plasmid (lanes 1-3) or with the pFPSl suppressor plasmid (lanes 4-6). Total RNA was prepared after growth on either 2% glucose 
(lanes 1,4), 2% glucose+2% maltose (lanes 2,5) or 2% maltose (lanes 3,6). The blots were probed with random primed MALR, MALS and 
MALT probes. Bottom panels show rRNA corresponding to each lane. 10 iig of total RNA were loaded on each lane for MALS and MALT, 
50 itg for MALR analysis. 
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PKA pathway modulates glucose repression of MAL gene 
expression. 
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